Trials / No Longer Available
No Longer AvailableNCT01968655
Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Baxalta now part of Shire · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
To provide emergency access to OBI-1 for patients with Acquired Hemophilia and a serious bleeding episode who do not have access to an active clinical study site associated with the OBI-1-301 study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | OBI-1 | OBI-1 is a B domain deleted recombinant porcine factor VIII |
Timeline
- First posted
- 2013-10-24
- Last updated
- 2021-05-05
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01968655. Inclusion in this directory is not an endorsement.